AI assistant
SYNLOGIC, INC. — Director's Dealing 2021
Mar 12, 2021
35028_dirs_2021-03-12_166e47fb-9c30-40e9-8c5b-7a03fe718f33.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SYNLOGIC, INC. (SYBX)
CIK: 0001527599
Period of Report: 2021-03-10
Reporting Person: Riese Richard J. (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-10 | Common Stock | A | 17500 | $0.00 | Acquired | 39000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-10 | Stock Option (right to buy) | $3.50 | A | 70000 | Acquired | 2031-03-10 | Common Stock (70000) | Direct |
Footnotes
F1: The shares of restricted stock were granted on March 10, 2021, and will vest beginning on April 1, 2021 (the "Vesting Start Date") in four equal annual installments on each anniversary of the Vesting Start Date, subject to the Reporting Person continuing to provide services to the Issuer as Chief Medical Officer through each such vesting date.
F2: The option will vest and become exercisable in equal monthly installments for forty-eight months beginning on April 1, 2021, with the first installment vesting on May 1, 2021 subject to the Reporting Person continuing to provide services to the Issuer as Chief Medical Officer through each such vesting date.